This report aims to provide a comprehensive presentation of the global market for Non-Invasive Prenatal Testing (NIPT), with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Invasive Prenatal Testing (NIPT).

The Non-Invasive Prenatal Testing (NIPT) market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Non-Invasive Prenatal Testing (NIPT) market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-Invasive Prenatal Testing (NIPT) manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

The global Non-Invasive Prenatal Testing (NIPT) market size in 2022 is 3561.37 million US dollars, and it is expected to be 7384.65 million US dollars by 2029, with a compound annual growth rate of 10.98% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Non-Invasive Prenatal Testing (NIPT) market include Agilent Technologies, Inc., Laboratory Corporation of America Holdings, Illumina, Inc., F. Hoffman-La Roche Ltd., and Yourgene Health. The share of the top 3 players in the Non-Invasive Prenatal Testing (NIPT) market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Non-Invasive Prenatal Testing (NIPT) market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. 0-12 weeks accounted for XX% of Non-Invasive Prenatal Testing (NIPT) market in 2022. 13-24 weeks share of XX%.
Diagnostic Centers accounted for XX% of the Non-Invasive Prenatal Testing (NIPT) market in 2022. Hospitals accounts for XX%.

Highlights-Regions

Americas
United States
Canada
Brazil
Argentina
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
MEA
Saudi Arabia
UAE
Turkey

Player list
Agilent Technologies, Inc.
Laboratory Corporation of America Holdings
Illumina, Inc.
F. Hoffman-La Roche Ltd.
Yourgene Health
Perkinelmer, Inc.
GE Medical and Pharmaceutical
Quest Diagnostics
Thermo Fisher Scientific, Inc.
Sequenom
Qiagen N.V.
Koninklijke Philips N.V.
Natera, Inc.
Beijing Genomics Institute
Pacific Biosciences of California, Inc.

Types list
0-12 weeks
13-24 weeks
25-36 weeks

Application list
Diagnostic Centers
Hospitals
Clinics
Others

Table of Content

1 Study Coverage
1.1 Non-Invasive Prenatal Testing (NIPT) Product Introduction
1.2 Market by Type
1.2.1 Global Non-Invasive Prenatal Testing (NIPT) Market Size Growth Rate by Type, 2018 VS 2023 VS 2029
1.3 Market by Application
1.3.1 Global Non-Invasive Prenatal Testing (NIPT) Market Size Growth Rate by Application, 2018 VS 2023 VS 2029
1.4 Global Non-Invasive Prenatal Testing (NIPT) Market by Region
1.4.1 Global Non-Invasive Prenatal Testing (NIPT) Market by Region: 2018 VS 2023 VS 2029
1.4.2 Global Non-Invasive Prenatal Testing (NIPT) Revenue Market
1.5 Study Objectives
1.6 Years Considered
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global Non-Invasive Prenatal Testing (NIPT) Revenue by Players
2.1.1 Global Non-Invasive Prenatal Testing (NIPT) Revenue by Players (2018-2023)
2.1.2 Global Non-Invasive Prenatal Testing (NIPT) Revenue Market Share by Players (2018-2023)
2.1.3 Global Top 5 and Top 10 Companies by Non-Invasive Prenatal Testing (NIPT) Revenue in 2023
2.2 Global Non-Invasive Prenatal Testing (NIPT) Gross Margin by Players
2.3 Analysis of Competitive Landscape
2.3.1 Players Market Concentration Ratio (CR5)
2.3.2 Global Non-Invasive Prenatal Testing (NIPT) Players Geographical Distribution
2.4 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 Agilent Technologies, Inc.
3.1.1 Agilent Technologies, Inc. Information
3.1.2 Agilent Technologies, Inc. Overview
3.1.3 Agilent Technologies, Inc. Non-Invasive Prenatal Testing (NIPT) Revenue and Gross Margin (2018-2023)
3.1.4 Agilent Technologies, Inc. Related Developments
3.2 Laboratory Corporation of America Holdings
3.2.1 Laboratory Corporation of America Holdings Information
3.2.2 Laboratory Corporation of America Holdings Overview
3.2.3 Laboratory Corporation of America Holdings Non-Invasive Prenatal Testing (NIPT) Revenue and Gross Margin (2018-2023)
3.2.4 Laboratory Corporation of America Holdings Related Developments
3.3 Illumina, Inc.
3.3.1 Illumina, Inc. Information
3.3.2 Illumina, Inc. Overview
3.3.3 Illumina, Inc. Non-Invasive Prenatal Testing (NIPT) Revenue and Gross Margin (2018-2023)
3.3.4 Illumina, Inc. Related Developments
3.4 F. Hoffman-La Roche Ltd.
3.4.1 F. Hoffman-La Roche Ltd. Information
3.4.2 F. Hoffman-La Roche Ltd. Overview
3.4.3 F. Hoffman-La Roche Ltd. Non-Invasive Prenatal Testing (NIPT) Revenue and Gross Margin (2018-2023)
3.4.4 F. Hoffman-La Roche Ltd. Related Developments
3.5 Yourgene Health
3.5.1 Yourgene Health Information
3.5.2 Yourgene Health Overview
3.5.3 Yourgene Health Non-Invasive Prenatal Testing (NIPT) Revenue and Gross Margin (2018-2023)
3.5.4 Yourgene Health Related Developments
3.6 Perkinelmer, Inc.
3.6.1 Perkinelmer, Inc. Information
3.6.2 Perkinelmer, Inc. Overview
3.6.3 Perkinelmer, Inc. Non-Invasive Prenatal Testing (NIPT) Revenue and Gross Margin (2018-2023)
3.6.4 Perkinelmer, Inc. Related Developments
3.7 GE Medical and Pharmaceutical
3.7.1 GE Medical and Pharmaceutical Information
3.7.2 GE Medical and Pharmaceutical Overview
3.7.3 GE Medical and Pharmaceutical Non-Invasive Prenatal Testing (NIPT) Revenue and Gross Margin (2018-2023)
3.7.4 GE Medical and Pharmaceutical Related Developments
3.8 Quest Diagnostics
3.8.1 Quest Diagnostics Information
3.8.2 Quest Diagnostics Overview
3.8.3 Quest Diagnostics Non-Invasive Prenatal Testing (NIPT) Revenue and Gross Margin (2018-2023)
3.8.4 Quest Diagnostics Related Developments
3.9 Thermo Fisher Scientific, Inc.
3.9.1 Thermo Fisher Scientific, Inc. Information
3.9.2 Thermo Fisher Scientific, Inc. Overview
3.9.3 Thermo Fisher Scientific, Inc. Non-Invasive Prenatal Testing (NIPT) Revenue and Gross Margin (2018-2023)
3.9.4 Thermo Fisher Scientific, Inc. Related Developments
3.10 Sequenom
3.10.1 Sequenom Information
3.10.2 Sequenom Overview
3.10.3 Sequenom Non-Invasive Prenatal Testing (NIPT) Revenue and Gross Margin (2018-2023)
3.10.4 Sequenom Related Developments
3.11 Qiagen N.V.
3.11.1 Qiagen N.V. Information
3.11.2 Qiagen N.V. Overview
3.11.3 Qiagen N.V. Non-Invasive Prenatal Testing (NIPT) Revenue and Gross Margin (2018-2023)
3.11.4 Qiagen N.V. Related Developments
3.12 Koninklijke Philips N.V.
3.12.1 Koninklijke Philips N.V. Information
3.12.2 Koninklijke Philips N.V. Overview
3.12.3 Koninklijke Philips N.V. Non-Invasive Prenatal Testing (NIPT) Revenue and Gross Margin (2018-2023)
3.12.4 Koninklijke Philips N.V. Related Developments
3.13 Natera, Inc.
3.13.1 Natera, Inc. Information
3.13.2 Natera, Inc. Overview
3.13.3 Natera, Inc. Non-Invasive Prenatal Testing (NIPT) Revenue and Gross Margin (2018-2023)
3.13.4 Natera, Inc. Related Developments
3.14 Beijing Genomics Institute
3.14.1 Beijing Genomics Institute Information
3.14.2 Beijing Genomics Institute Overview
3.14.3 Beijing Genomics Institute Non-Invasive Prenatal Testing (NIPT) Revenue and Gross Margin (2018-2023)
3.14.4 Beijing Genomics Institute Related Developments
3.15 Pacific Biosciences of California, Inc.
3.15.1 Pacific Biosciences of California, Inc. Information
3.15.2 Pacific Biosciences of California, Inc. Overview
3.15.3 Pacific Biosciences of California, Inc. Non-Invasive Prenatal Testing (NIPT) Revenue and Gross Margin (2018-2023)
3.15.4 Pacific Biosciences of California, Inc. Related Developments
4 Market Size by Type
4.1 Global Non-Invasive Prenatal Testing (NIPT) Revenue by Type
4.2 Global Non-Invasive Prenatal Testing (NIPT) Market Size Growth by Type 2018-2023
5 Market Size by Application
5.1 Global Non-Invasive Prenatal Testing (NIPT) Revenue by Application
5.2 Global Non-Invasive Prenatal Testing (NIPT) Market Size Growth by Application 2018-2023
6 Global Non-Invasive Prenatal Testing (NIPT) Market Insights
6.1 Global Non-Invasive Prenatal Testing (NIPT) Market Revenue 2018-2023
6.2 Global Non-Invasive Prenatal Testing (NIPT) Revenue by Region
6.3 Americas
6.4 Europe
6.5 Asia-Pacific
6.6 Middle East & Africa
7 Americas
7.1 Americas Non-Invasive Prenatal Testing (NIPT) Market Size by Country
7.1.1 Americas Non-Invasive Prenatal Testing (NIPT) Revenue by Country (2018-2023)
7.1.2 U.S.
7.1.3 Canada
7.1.4 Mexico
7.1.5 Brazil
7.1.6 Argentina
8 Europe
8.1 Europe Non-Invasive Prenatal Testing (NIPT) Market Size by Country
8.1.1 Europe Non-Invasive Prenatal Testing (NIPT) Revenue by Country (2018-2023)
8.1.2 Germany
8.1.3 France
8.1.4 U.K.
8.1.5 Italy
8.1.6 Russia
9 Asia Pacific
9.1 Asia Pacific Non-Invasive Prenatal Testing (NIPT) Market Size by Region
9.1.1 Asia Pacific Non-Invasive Prenatal Testing (NIPT) Revenue by Region (2018-2023)
9.1.2 China
9.1.3 Japan
9.1.4 South Korea
9.1.5 India
9.1.6 Southeast Asia
9.1.7 Australia
10 Middle East and Africa
10.1 Middle East and Africa Non-Invasive Prenatal Testing (NIPT) Market Size by Country
10.1.1 Middle East and Africa Non-Invasive Prenatal Testing (NIPT) Revenue by Country (2018-2023)
10.1.2 Turkey
10.1.3 Saudi Arabia
10.1.4 U.A.E
11 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
11.1 Non-Invasive Prenatal Testing (NIPT) Industry Trends
11.2 Non-Invasive Prenatal Testing (NIPT) Market Drivers
11.3 Non-Invasive Prenatal Testing (NIPT) Market Challenges
11.4 Non-Invasive Prenatal Testing (NIPT) Market Restraints
12 Non-Invasive Prenatal Testing (NIPT) Forecasted Market Size by Type
12.1 Global Non-Invasive Prenatal Testing (NIPT) Forecasted Revenue by Type
12.2 Global Non-Invasive Prenatal Testing (NIPT) Forecasted Market Size Growth by Type 2023-2029
13 Non-Invasive Prenatal Testing (NIPT) Forecasted Market Size by Application
13.1 Global Non-Invasive Prenatal Testing (NIPT) Forecasted Revenue by Application
13.2 Global Non-Invasive Prenatal Testing (NIPT) Forecasted Market Size Growth by Application 2023-2029
14 Global Non-Invasive Prenatal Testing (NIPT) Market Forecasts
14.1 Global Non-Invasive Prenatal Testing (NIPT) Market Revenue Forecasts 2023-2029
14.2 Global Non-Invasive Prenatal Testing (NIPT) Forecasts Revenue by Region
14.3 Americas
14.3.1 Americas Non-Invasive Prenatal Testing (NIPT) Forecasts Revenue by Country (2018-2023)
14.4 Europe
14.4.1 Europe Non-Invasive Prenatal Testing (NIPT) Forecasts Revenue by Country (2018-2023)
14.5 Asia-Pacific
14.5.1 Asia Pacific Non-Invasive Prenatal Testing (NIPT) Forecasts Revenue by Country (2018-2023)
14.6 Middle East & Africa
14.6.1 Middle East and Africa Non-Invasive Prenatal Testing (NIPT) Forecasts Revenue by Country (2018-2023)
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer

List of Tables and Figures

Figure Non-Invasive Prenatal Testing (NIPT) Picture
Table Product Definition of Non-Invasive Prenatal Testing (NIPT)
Table Global Non-Invasive Prenatal Testing (NIPT) Market Size Growth Rate by Type, 2018 VS 2023 VS 2029
Table Global Non-Invasive Prenatal Testing (NIPT) Market Size Growth Rate by Application, 2018 VS 2023 VS 2029
Table Global Non-Invasive Prenatal Testing (NIPT) Market by Region: 2018 VS 2023 VS 2029
Figure Global Non-Invasive Prenatal Testing (NIPT) Revenue Market Size & Forecasts 2018-2029
Figure Years Considered
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Global Non-Invasive Prenatal Testing (NIPT) Revenue by Players (2018-2023)
Table Global Non-Invasive Prenatal Testing (NIPT) Revenue Market Share by Players (2018-2023)
Figure Top 5 Largest Players of Non-Invasive Prenatal Testing (NIPT) in 2023
Figure Top 10 Largest Players of Non-Invasive Prenatal Testing (NIPT) in 2023
Table Global Non-Invasive Prenatal Testing (NIPT) Gross Margin by Players
Table Players Market Concentration Ratio (CR5)
Table Global Non-Invasive Prenatal Testing (NIPT) Players Geographical Distribution
Table Mergers & Acquisitions, Expansion Plans
Table Company Profiles
Table Agilent Technologies, Inc. Overview
Table Agilent Technologies, Inc. Revenue, Gross, Gross Margin 2018-2023
Table Agilent Technologies, Inc. Related Developments
Table Company Profiles
Table Laboratory Corporation of America Holdings Overview
Table Laboratory Corporation of America Holdings Revenue, Gross, Gross Margin 2018-2023
Table Laboratory Corporation of America Holdings Related Developments
Table Company Profiles
Table Illumina, Inc. Overview
Table Illumina, Inc. Revenue, Gross, Gross Margin 2018-2023
Table Illumina, Inc. Related Developments
Table Company Profiles
Table F. Hoffman-La Roche Ltd. Overview
Table F. Hoffman-La Roche Ltd. Revenue, Gross, Gross Margin 2018-2023
Table F. Hoffman-La Roche Ltd. Related Developments
Table Company Profiles
Table Yourgene Health Overview
Table Yourgene Health Revenue, Gross, Gross Margin 2018-2023
Table Yourgene Health Related Developments
Table Company Profiles
Table Perkinelmer, Inc. Overview
Table Perkinelmer, Inc. Revenue, Gross, Gross Margin 2018-2023
Table Perkinelmer, Inc. Related Developments
Table Company Profiles
Table GE Medical and Pharmaceutical Overview
Table GE Medical and Pharmaceutical Revenue, Gross, Gross Margin 2018-2023
Table GE Medical and Pharmaceutical Related Developments
Table Company Profiles
Table Quest Diagnostics Overview
Table Quest Diagnostics Revenue, Gross, Gross Margin 2018-2023
Table Quest Diagnostics Related Developments
Table Company Profiles
Table Thermo Fisher Scientific, Inc. Overview
Table Thermo Fisher Scientific, Inc. Revenue, Gross, Gross Margin 2018-2023
Table Thermo Fisher Scientific, Inc. Related Developments
Table Company Profiles
Table Sequenom Overview
Table Sequenom Revenue, Gross, Gross Margin 2018-2023
Table Sequenom Related Developments
Table Company Profiles
Table Qiagen N.V. Overview
Table Qiagen N.V. Revenue, Gross, Gross Margin 2018-2023
Table Qiagen N.V. Related Developments
Table Company Profiles
Table Koninklijke Philips N.V. Overview
Table Koninklijke Philips N.V. Revenue, Gross, Gross Margin 2018-2023
Table Koninklijke Philips N.V. Related Developments
Table Company Profiles
Table Natera, Inc. Overview
Table Natera, Inc. Revenue, Gross, Gross Margin 2018-2023
Table Natera, Inc. Related Developments
Table Company Profiles
Table Beijing Genomics Institute Overview
Table Beijing Genomics Institute Revenue, Gross, Gross Margin 2018-2023
Table Beijing Genomics Institute Related Developments
Table Company Profiles
Table Pacific Biosciences of California, Inc. Overview
Table Pacific Biosciences of California, Inc. Revenue, Gross, Gross Margin 2018-2023
Table Pacific Biosciences of California, Inc. Related Developments
Table Global Non-Invasive Prenatal Testing (NIPT) Revenue by Type (2018-2023)
Table Global Non-Invasive Prenatal Testing (NIPT) Revenue Share by Type (2018-2023)
Table Global Non-Invasive Prenatal Testing (NIPT) Revenue by Application (2018-2023)
Table Global Non-Invasive Prenatal Testing (NIPT) Revenue Share by Application (2018-2023)
Figure Global Non-Invasive Prenatal Testing (NIPT) Market Revenue 2018-2023
Table Global Non-Invasive Prenatal Testing (NIPT) Revenue by Region (2018-2023)
Table Global Non-Invasive Prenatal Testing (NIPT) Revenue Share by Region (2018-2023)
Figure Americas Non-Invasive Prenatal Testing (NIPT) Revenue (2018-2023)
Figure Europe Non-Invasive Prenatal Testing (NIPT) Revenue (2018-2023)
Figure Asia-Pacific Non-Invasive Prenatal Testing (NIPT) Revenue (2018-2023)
Figure Middle East & Africa Non-Invasive Prenatal Testing (NIPT) Revenue (2018-2023)
Table Americas Non-Invasive Prenatal Testing (NIPT) Revenue by Country (2018-2023)
Table Americas Non-Invasive Prenatal Testing (NIPT) Revenue Share by Country (2018-2023)
Figure United States Non-Invasive Prenatal Testing (NIPT) Revenue Market Size (2018-2023)
Figure Canada Non-Invasive Prenatal Testing (NIPT) Revenue Market Size (2018-2023)
Figure Mexico Non-Invasive Prenatal Testing (NIPT) Revenue Market Size (2018-2023)
Figure Brazil Non-Invasive Prenatal Testing (NIPT) Revenue Market Size (2018-2023)
Figure Argentina Non-Invasive Prenatal Testing (NIPT) Revenue Market Size (2018-2023)
Table Europe Non-Invasive Prenatal Testing (NIPT) Revenue by Country (2018-2023)
Table Europe Non-Invasive Prenatal Testing (NIPT) Revenue Share by Country (2018-2023)
Figure Germany Non-Invasive Prenatal Testing (NIPT) Revenue Market Size (2018-2023)
Figure France Non-Invasive Prenatal Testing (NIPT) Revenue Market Size (2018-2023)
Figure U.K. Non-Invasive Prenatal Testing (NIPT) Revenue Market Size (2018-2023)
Figure Italy Non-Invasive Prenatal Testing (NIPT) Revenue Market Size (2018-2023)
Figure Russia Non-Invasive Prenatal Testing (NIPT) Revenue Market Size (2018-2023)
Table Asia Pacific Non-Invasive Prenatal Testing (NIPT) Revenue by Region (2018-2023)
Table Asia Pacific Non-Invasive Prenatal Testing (NIPT) Revenue Share by Region (2018-2023)
Figure China Non-Invasive Prenatal Testing (NIPT) Revenue Market Size (2018-2023)
Figure Japan Non-Invasive Prenatal Testing (NIPT) Revenue Market Size (2018-2023)
Figure South Korea Non-Invasive Prenatal Testing (NIPT) Revenue Market Size (2018-2023)
Figure India Non-Invasive Prenatal Testing (NIPT) Revenue Market Size (2018-2023)
Figure Southeast Asia Non-Invasive Prenatal Testing (NIPT) Revenue Market Size (2018-2023)
Figure Australia Non-Invasive Prenatal Testing (NIPT) Revenue Market Size (2018-2023)
Table Middle East and Africa Non-Invasive Prenatal Testing (NIPT) Revenue by Country (2018-2023)
Table Middle East and Africa Non-Invasive Prenatal Testing (NIPT) Revenue Share by Country (2018-2023)
Figure Turkey Non-Invasive Prenatal Testing (NIPT) Revenue Market Size (2018-2023)
Figure Saudi Arabia Non-Invasive Prenatal Testing (NIPT) Revenue Market Size (2018-2023)
Figure U.A.E Non-Invasive Prenatal Testing (NIPT) Revenue Market Size (2018-2023)
Table Global Non-Invasive Prenatal Testing (NIPT) Forecasted Revenue by Type (2018-2023)
Table Global Non-Invasive Prenatal Testing (NIPT) Forecasted Revenue Share by Type (2018-2023)
Table Global Non-Invasive Prenatal Testing (NIPT) Forecasted Revenue by Application (2018-2023)
Table Global Non-Invasive Prenatal Testing (NIPT) Forecasted Revenue Share by Application (2018-2023)
Figure Global Non-Invasive Prenatal Testing (NIPT) Market Revenue Forecasts 2023-2029
Table Global Non-Invasive Prenatal Testing (NIPT) Forecasts Revenue by Region (2023-2029)
Table Global Non-Invasive Prenatal Testing (NIPT) Forecasts Revenue Share by Region (2023-2029)
Figure Americas Non-Invasive Prenatal Testing (NIPT) Forecasts Revenue and Growth (2023-2029)
Table Americas Non-Invasive Prenatal Testing (NIPT) Forecasts Revenue by Country (2018-2023)
Table Americas Non-Invasive Prenatal Testing (NIPT) Forecasts Revenue Share by Country (2018-2023)
Figure Europe Non-Invasive Prenatal Testing (NIPT) Forecasts Revenue and Growth (2023-2029)
Table Europe Non-Invasive Prenatal Testing (NIPT) Forecasts Revenue by Country (2018-2023)
Table Europe Non-Invasive Prenatal Testing (NIPT) Forecasts Revenue Share by Country (2018-2023)
Figure Asia-Pacific Non-Invasive Prenatal Testing (NIPT) Forecasts Revenue and Growth (2023-2029)
Table Asia Pacific Non-Invasive Prenatal Testing (NIPT) Forecasts Revenue by Country (2018-2023)
Table Asia Pacific Non-Invasive Prenatal Testing (NIPT) Forecasts Revenue Share by Country (2018-2023)
Figure Middle East & Africa Non-Invasive Prenatal Testing (NIPT) Forecasts Revenue and Growth (2023-2029)
Table Middle East and Africa Non-Invasive Prenatal Testing (NIPT) Forecasts Revenue by Country (2018-2023)
Table Middle East and Africa Non-Invasive Prenatal Testing (NIPT) Forecasts Revenue Share by Country (2018-2023)
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report